Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IL9R pseudogene 3 (IL9RP3) is a pseudogene of the interleukin 9 receptor (IL9R) and does not encode a functional protein due to inactivating mutations, deletions, and lack of critical coding regions.[2] It is one of several IL9R-related pseudogenes identified on human chromosomes 9q34, 10p15, 16p13.3, and 18p11.3, believed to have arisen through evolutionary translocations and gene duplications. Unlike the functional IL9R gene, IL9RP3 does not participate in cytokine signaling or immune response and is not considered a druggable target, nor does it have established roles in disease pathology or therapeutic development.[2]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on IL9R pseudogene 3 (IL9RP3).